NO974956L - Terapeutisk sammensetning for artritis - Google Patents
Terapeutisk sammensetning for artritisInfo
- Publication number
- NO974956L NO974956L NO974956A NO974956A NO974956L NO 974956 L NO974956 L NO 974956L NO 974956 A NO974956 A NO 974956A NO 974956 A NO974956 A NO 974956A NO 974956 L NO974956 L NO 974956L
- Authority
- NO
- Norway
- Prior art keywords
- arthritis
- agent
- administration
- inflammatory
- acting
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 4
- 230000000202 analgesic effect Effects 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det blir fremskaffet et farmasøytisk middel som viser hurtigvirkende og vedvarende anti-inflammatorisk analgesisk virkning mot kronisk artritis med lav fremtreden av bieffekter. En farmasøytisk sammensetning omfattende en kombinasjon av et quinolin-/quina- zolinserier profylaktisk/terapeutisk middel for artritis og hurtigvirkende anti-inflam- matorisk analgesisk middel omfattende (1) en cyklooksygenaseinhibitor, (2) et sentralt analgesika, (3) et steroid eller (4) et anti-inflammatorisk enzym-middel. Foreliggende preparat viser utmerkede effekter mot artritis fra administrasjon for å sikre stabil anti-inflammatorisk analgesisk virkning med lav fremtreden av bieffekter selv ved kronisk administrasjon, forutsatt at medikamentsammensetning, administrasjonsmetode og dose er passende valgt ifølge symptomene.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10631695 | 1995-04-28 | ||
| JP27085695 | 1995-10-19 | ||
| PCT/JP1996/001102 WO1996033717A1 (en) | 1995-04-28 | 1996-04-24 | Therapeutic composition for arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO974956L true NO974956L (no) | 1997-10-27 |
| NO974956D0 NO974956D0 (no) | 1997-10-27 |
Family
ID=26446436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO974956A NO974956D0 (no) | 1995-04-28 | 1997-10-27 | Terapeutisk sammensetning for artritis |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0830133A1 (no) |
| KR (1) | KR19990008148A (no) |
| AU (1) | AU715358B2 (no) |
| CA (1) | CA2216138A1 (no) |
| HU (1) | HUP9801628A2 (no) |
| NO (1) | NO974956D0 (no) |
| WO (1) | WO1996033717A1 (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262269B1 (en) | 1997-02-04 | 2001-07-17 | Trega Biosciences, Inc. | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
| CA2279977A1 (en) * | 1997-02-04 | 1998-08-06 | John S. Kiely | 4-substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries |
| DE60129445T2 (de) | 2000-08-09 | 2008-04-24 | F. Hoffmann-La Roche Ag | Quinolin-derivate als antientzündungsmittel |
| EP1354603A1 (en) * | 2000-12-26 | 2003-10-22 | Takeda Chemical Industries, Ltd. | Concomitant drugs |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968701A (en) * | 1988-04-26 | 1990-11-06 | E. I. Du Pont De Nemours And Company | 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents |
| DE68908459T2 (de) * | 1988-04-26 | 1994-04-07 | Asahi Glass Co Ltd | Prepolymerzusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung. |
| US5187180A (en) * | 1990-07-26 | 1993-02-16 | Merck Frosst Canada, Inc. | (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes |
| IE920499A1 (en) * | 1991-02-21 | 1992-08-26 | Merck Frosst Canada Inc | Quinoline-containing ketoacids as leukotriene antagonists |
| TW232013B (no) * | 1992-04-24 | 1994-10-11 | Takeda Pharm Industry Co Ltd | |
| KR100224135B1 (ko) * | 1993-01-28 | 1999-10-15 | 다께다 구니오 | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 |
| US5641788A (en) * | 1994-06-07 | 1997-06-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives and pharmaceutical composition containing them |
-
1996
- 1996-04-24 AU AU55136/96A patent/AU715358B2/en not_active Ceased
- 1996-04-24 EP EP96912213A patent/EP0830133A1/en not_active Withdrawn
- 1996-04-24 WO PCT/JP1996/001102 patent/WO1996033717A1/en not_active Ceased
- 1996-04-24 KR KR1019970707673A patent/KR19990008148A/ko not_active Withdrawn
- 1996-04-24 CA CA002216138A patent/CA2216138A1/en not_active Abandoned
- 1996-04-24 HU HU9801628A patent/HUP9801628A2/hu unknown
-
1997
- 1997-10-27 NO NO974956A patent/NO974956D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2216138A1 (en) | 1996-10-31 |
| AU715358B2 (en) | 2000-01-20 |
| WO1996033717A1 (en) | 1996-10-31 |
| KR19990008148A (ko) | 1999-01-25 |
| AU5513696A (en) | 1996-11-18 |
| HUP9801628A2 (hu) | 1999-01-28 |
| EP0830133A1 (en) | 1998-03-25 |
| NO974956D0 (no) | 1997-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1637A (en) | Celecoxib compositions. | |
| BR0013704A (pt) | Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares | |
| NO922004D0 (no) | Oralt preparat for behandling av inflammatoriske tarmsykdommer | |
| NO934284L (no) | Farmasoeytisk preparat inneholdende et definert lipidsystem | |
| SE9704870D0 (sv) | New pharmaceutical formulation I | |
| ATE486840T1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
| ATE277596T1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
| WO1998019649A3 (en) | Methods and compositions for inhibition of angiogenesis | |
| SE9602442D0 (sv) | Administration of pharmaceuticals | |
| BR9810520A (pt) | Inibidor do fator xa isolado ou em combinação com um anti-agregador plaquetário, contra a trambose arterial | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| NO954878L (no) | Pyrrolderivater | |
| WO2000033790A3 (en) | Methods and compositions for prevention and treatment of arterial lesions with non-steroidal anti-inflammatory drugs | |
| BR9813179A (pt) | Formulação de liberação prolongada | |
| ES2126123T3 (es) | Empleo de cineol o mentol para el tratamiento de asma. | |
| BR9803233A (pt) | Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares. | |
| NO974956L (no) | Terapeutisk sammensetning for artritis | |
| AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
| DK0862454T3 (da) | CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner | |
| NO952234L (no) | Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft | |
| NO962503L (no) | Anvendelse av penoksyfyllin ved behandling av multippel sklerose | |
| NO20050933L (no) | Pravastatin farmasoytiske formuleringer og fremgangsmater for anvendelse derav | |
| EA199700025A1 (ru) | Применение олигосахарида и аспирина для приготовления медикаментов, предназначенных для лечения тромбоэмболических заболеваний, фармацевтическая композиция, способ лечения | |
| AR033424A1 (es) | Composiciones farmaceuticas | |
| BR0010449A (pt) | 14beta-h-esteróis, composições farmacêuticas que compreendem os mesmos e uso destes derivados para a preparação de medicamentos reguladores da meiose |